SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-007677
Filing Date
2020-06-22
Accepted
2020-06-22 06:02:50
Documents
9
Period of Report
2020-08-04
Effectiveness Date
2020-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20200804xdef14a.htm DEF 14A 810283
2 GRAPHIC tmb-20200804xdef14a015.jpg GRAPHIC 122655
3 GRAPHIC tmb-20200804xdef14a018.jpg GRAPHIC 106998
4 GRAPHIC tmb-20200804xdef14a014.jpg GRAPHIC 157534
5 GRAPHIC tmb-20200804xdef14a017.jpg GRAPHIC 129807
6 GRAPHIC tmb-20200804xdef14a001.jpg GRAPHIC 4705
7 GRAPHIC tmb-20200804xdef14a019.jpg GRAPHIC 126897
8 GRAPHIC tmb-20200804xdef14a016.jpg GRAPHIC 150815
9 GRAPHIC tmb-20200804xdef14a002.jpg GRAPHIC 4283
  Complete submission text file 0001558370-20-007677.txt   1919412
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 20977083
SIC: 3841 Surgical & Medical Instruments & Apparatus